Coffee Shop | vitamins herbs supplements longevity and aging


Previous 10 | Next 10 
From: Pogeu Mahone5/4/2012 1:24:17 PM
   of 10256
 
It is all BS all of the time!
18 hours in a hospital and they say you were not admitted!

Plain BS!
================================================


Patients held for observation can face steep drug bills

Sudden chest pains landed Diane Zachor in a Duluth, Minn., hospital overnight, but weeks later she had another shock — a $442 bill for the everyday drugs she also takes at home, including more than a half dozen common medicines to control diabetes, heart problems and high cholesterol.
By Julia Cheng, for USA TODAY

Diane Zachor was shocked by bills for medications administered during a hospital visit.

By Julia Cheng, for USA TODAY

Diane Zachor was shocked by bills for medications administered during a hospital visit. She couldn't believe some of these prices they charge," said Zachor, 66. "It's just atrocious." For the price she was charged for her insulin during her 18-hour stay at St. Luke's Hospital, Zachor would have enough to cover her out-of-pocket expenses for a three-month supply under her private Medicare Advantage plan. The tab for one water pill to control high blood pressure could buy a three-week supply. And the bill for one calcium tablet could purchase enough for three weeks, when she gets them over the counter from a national chain pharmacy.

Even though her health plan covers medical and drug expenses, her policy would not pay the hospital drug bill because St. Luke's never formally admitted her, instead billing the visit as observation care, which is considered outpatient service.

That observation label excludes thousands of patients every year from full Medicare coverage. Many have spent more than a day in the hospital and had regular hospital rooms and service and, as with Zachor, never realized they weren't admitted.


These observation patients might wind up paying a larger share of their hospital bills than inpatients, since they usually have a co-payment for doctors' fees and each hospital service.

But Medicare doesn't pay at all for routine drugs that observation patients need for chronic conditions such as diabetes, high blood pressure or high cholesterol — drugs that Zachor could have brought from home if the hospital allowed it and she had time to get them. Medicare has no rules for what hospitals can bill for non-covered drugs, so they can charge any amount.

A shock, afterward

It's an unwelcome surprise for patients who may not get the bad news until they receive a hospital bill. Medicare has no rules requiring hospitals to tell patients when they are in observation status or that they will be responsible for paying any non-covered Medicare services, said Ellen Griffith, a spokeswoman for the U.S. Centers for Medicare & Medicaid Services.

"St. Luke's carries out 'observation' and all other health care policies as prescribed by Medicare rules," said Mary Greene, a St. Luke's Hospital representative, in an e-mail. She referred any questions to Medicare.

Drug prices have also surprised seniors in other parts of the country:

•In Missouri, several Medicare observation patients were billed $18 for one baby aspirin, said Ruth Dockins, a senior advocate at the Southeast Missouri Area Agency on Aging.

•Pearl Beras, 85, of Boca Raton, Fla., said in an interview that her hospital charged $71 for one blood pressure pill for which her neighborhood pharmacy charges 16 cents.

•In California, a hospital billed several patients $111 for one pill that reduces nausea; for the same price, they could have bought 95 of the pills at a local pharmacy, said Tamara McKee, program manager for the Health Insurance Counseling & Advocacy Program at the Alliance on Aging in Monterey County, Calif., who handled at least 20 complaints last year from Medicare beneficiaries about excessive hospital drug bills.

The most recent government statistics show the number of observation claims that hospitals submitted to Medicare rose 46% to 1.4 million from 2006 to 2010, and the number of cases lasting longer than 48 hours more than tripled.

The American Hospital Association, in a 2010 letter to Medicare officials, said several factors explain that growth, including increasingly restrictive Medicare criteria for the hospital admission and rising use of audits to monitor hospital decisions and billing. In addition, it said, physicians sometimes try to keep seniors in the hospital because they may not be well enough to be home, even when they're not sick enough to be admitted.

"I don't blame the hospitals," said attorney Gill Deford at the Center for Medicare Advocacy, based in Connecticut, which has filed a class-action lawsuit against the federal government on behalf of observation patients who, because of their observation status, become ineligible for Medicare coverage for nursing home care when they leave the hospital.

The lawsuit seeks to either eliminate observation status or require hospitals to tell patients when they're admitted for observation and allow them to appeal the designation. Observation status "is a big money-saver for the Medicare program," he said. Medicare officials recommend to hospitals — but do not require — that patients remain under observation for no more than 24 to 48 hours. After that, the patients should be switched to inpatient status or discharged, the officials recommend. But patients can linger in observation for several days and often don't know they haven't been admitted.

Difference in pricing

Since the program does not limit the prices for drugs that Medicare doesn't cover, that can create an opportunity that hospitals might find hard to resist.

Hospitals use their pharmacies to help generate revenue to subsidize the other operating costs of the facility, said Miriam Mobley Smith, dean of the College of Pharmacy at Chicago State University. She said the "upcharge" is based on numerous factors, including personnel, insurance and facility costs.

"I'm not justifying the charges," she said, "but there's a huge difference between the cost of operating a retail pharmacy compared to a hospital pharmacy."

Even patients with private Medicare Part D drug insurance may find that their policies don't cover their everyday — or "self-administered" — drugs given to them in the hospital.

"These drugs may be covered under certain circumstances," according to the Medicare website. But there is no requirement that Part D beneficiaries must be fully reimbursed for these drugs.

Seniors advocate Dockins said that requiring hospital pharmacies to participate in the Medicare Part D drug plans would help control pricing because the beneficiaries would get discounts negotiated by the plan.

To avoid drug charges, she tells seniors to bring their pills in the original bottles when they go into the hospital. But hospitals are not required to let patients use their own medicine from home, said Leta Blank, coordinator for the Senior Health Insurance Assistance Program in Montgomery County, Md.

Dockins suggests that low-income seniors apply for a hospital's charity care program so that the charges can be waived or reduced, if they qualify.

Zachor, who works as an office manager for the Minnesota Citizens Federation, a consumer advocacy group, contacted her Medicare Advantage plan to appeal its decision to not cover her hospital drug bill.

In February, her insurer said it requires hospitals with which it contracts "to notify a member before delivering a non-covered service." Because the hospital didn't obtain Zachor's written consent to accept those charges, the plan's rules say the hospital cannot bill her for them.

However, other Medicare Advantage plans — which cover about a quarter of Medicare beneficiaries — may simply follow the traditional Medicare program, which does not require advance notice. Beneficiaries should check with their insurance companies.

Zachor's $442 drug bill was scrapped. She had to pay only $50, the co-pay for an emergency room visit.

"What if I didn't know there was a route to go to appeal to my plan?" Zachor said. "I was thinking about other people older than myself who don't know what to do, and they would probably have to go without food or medications — for how long — to pay a bill they didn't have to pay."

Kaiser Health News is an editorially independent program of the Henry J. Kaiser Family Foundation, a non-profit, non-partisan health policy research and communication organization not affiliated with Kaiser Permanente.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Pogeu Mahone who wrote (8605)5/4/2012 1:27:41 PM
From: joseffy   of 10256
 
Everything is a racket.

Give us your money, money money.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: joseffy who wrote (8606)5/4/2012 2:20:34 PM
From: Elmer Phud   of 10256
 
This is the way they recoup some of the expenses for the uninsured.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: joseffy who wrote (8602)5/4/2012 3:38:45 PM
From: E. Charters2 Recommendations   of 10256
 
Well I guess the philosophy is, if they are gonna die, it's no use spending money on 'em. Making them any smarter is wasting dollars on corpses.

On the other hand, given the status of education in schools today, maybe it's a blessing in disguise.

Perhaps they are giving parents a way out.

You don't really learn anything in school that is useful. It is a socialization program for cheating robots.

Maybe there is a herbal treatment for it.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: E. Charters who wrote (8608)5/4/2012 3:41:53 PM
From: Elmer Phud1 Recommendation   of 10256
 
Maybe there is a herbal treatment for it.

Yes, there is. Hemlock.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Elmer Phud who wrote (8609)5/4/2012 3:43:50 PM
From: E. Charters   of 10256
 
I owe a cock to Asclepius.

Share Recommend | Keep | Reply | Mark as Last Read

To: Elmer Phud who wrote (8607)5/5/2012 10:07:38 AM
From: Pogeu Mahone   of 10256
 
Monday, April 30, 2012
Scientists Uncover Exciting Lead Into Premature Ageing And Heart Disease

1. Scientists have discovered that they can dramatically increase the life span of mice with progeria (premature ageing disease) and heart disease (caused by Emery-Dreifuss muscular dystrophy) by reducing levels of a protein called SUN1. This research was done by A*STAR’s Institute of Medical Biology (IMB) in collaboration with their partners at the National Institute of Allergy and Infectious Diseases in the United States and the Institute of Cellular and System Medicine in Taiwan. Their findings were published in the prestigious scientific journal, Cell, on 27th April 2012 and provide an exciting lead into developing new methods to treat premature aging and heart disease.


2. Children with progeria suffer symptoms of premature ageing and mostly die in their early teens from either heart attack or stroke. Individuals with Emery-Dreifuss muscular dystrophy (AD-EDMD) suffer from muscle wasting and cardiomyopathy, a type of heart disease that weakens and enlarges the heart muscle making it harder for the heart to pump blood and deliver it to the rest of the body leading to heart failure. Both diseases are caused by mutations in Lamin A, a protein in the membrane surrounding a cell’s nucleus which provides mechanical support to the nucleus. SUN1 is a protein also found in the inner nuclear membrane, but there have been no previous studies to show how SUN1 interacts with the Lamin proteins.
3. The scientists wanted to investigate if SUN1 had any involvement in diseases caused by mutations in Lamin A, so they inactivated SUN1 in mouse models developed for progeria and AD-EDMD. These mouse models for progeria and AD-EDMD usually thrive poorly and have markedly short life spans as they die from premature ageing and heart failure respectively. However, by inactivating SUN1 and reducing SUN1 levels in these mouse models, the scientists observed that the life spans of the mouse models for progeria and AD-EDMD doubled and tripled respectively.
4. “We actually expected that knocking out Sun1 in these mouse models would worsen their conditions and cause them to die faster but surprisingly we observed the opposite. This is the first time that Sun1 protein has been implicated in diseases linked to Lamin A and it is exciting how basic research has led to a discovery that can potentially have significant impact on us,” said Rafidah Abdul Mutalif, who is pursuing her PhD at IMB and one of the main authors of this paper.
5. Prof. Colin Stewart, Principle Investigator at IMB, said, “Notably, the heart muscle of the mice was restored to near normal function and cardiac function improved when the levels of SUN1 were reduced. Mutations in Lamin A are frequently reported as a cause of heart disease and especially within a group of hereditary cardiomyopathies. This opens up a possibility that from these observations, reduction in SUN1 maybe of therapeutic use for other forms of heart disease. We are very excited about this discovery and look forward to further pursuing this lead which could potentially lead to development of new treatments for heart diseases.”

Notes for editor:

The research findings described in this news release can be found in the 27 Apr issue of Cell, Chen, C-Y et al 2012 Accumulation of the Inner Nuclear Envelope Protein Sun1 Is Pathogenic in Progeric and Dystrophic Laminopathies Cell 149

Agency for Science, Technology and Research (A*STAR)

For media queries, please contact:

Ms Ong Siok Ming
Senior Officer, Corporate Communications
Agency for Science, Technology and Research
Tel: (+65) 6826 6254
Email: ong_siok_ming@a-star.edu.sg

About the Institute of Medical Biology (IMB)
IMB is one of the Biomedical Sciences Institutes of the Agency for Science, Technology and Research (A*STAR). It was formed in 2007, the 7th and youngest of the BMRC Research Institutes, with a mission to study mechanisms of human disease in order to discover new and effective therapeutic strategies for improved quality of life. From 2011, IMB also hosts the inter-research institute Skin Biology Cluster platform.
IMB has 20 research teams of international excellence in stem cells, genetic diseases, cancer and skin and epithelial biology, and works closely with clinical collaborators to target the challenging interface between basic science and clinical medicine. Its growing portfolio of strategic research topics is targeted at translational research on the mechanisms of human diseases, with a cell-to-tissue emphasis that can help identify new therapeutic strategies for disease amelioration, cure and eradication.
For more information about IMB, please visit www.imb.a-star.edu.sg.

About the Agency for Science, Technology and Research (A*STAR)

The Agency for Science, Technology and Research (A*STAR) is the lead agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. A*STAR oversees 14 biomedical sciences and physical sciences and engineering research institutes, and six consortia & centres, located in Biopolis and Fusionopolis as well as their immediate vicinity.
A*STAR supports Singapore's key economic clusters by providing intellectual, human and industrial capital to its partners in industry. It also supports extramural research in the universities, and with other local and international partners.

For more information about A*STAR, please visit www.a-star.edu.sg.

Download PDF




Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Pogeu Mahone who wrote (8611)5/5/2012 10:57:19 AM
From: Elmer Phud   of 10256
 
Pogeu

Do you see any significance in this article for those of us who are not mice with progeria?

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (2)

To: Elmer Phud who wrote (8612)5/5/2012 2:02:28 PM
From: Pogeu Mahone   of 10256
 
got cheese-vbg-

Share Recommend | Keep | Reply | Mark as Last Read

To: Elmer Phud who wrote (8612)5/5/2012 3:56:37 PM
From: joseffy   of 10256
 
Old saying:

A MAN IS NOT A MOUSE

Share Recommend | Keep | Reply | Mark as Last Read
Previous 10 | Next 10 

Copyright © 1995-2013 Knight Sac Media. All rights reserved.